The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...

PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

A successful monoclonal antibody could undergo scale-up several times across the span of its commercial life, each stage presenting new complexities during sterile fill-finish. As more sponsors turn ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

Mubadala Investment Company (Mubadala), announced the official commencement of the Al Maryah Waterfront enhancement project, ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

PCI asks State Councils to submit consolidated data of pharmacists for HPR: Our Bureau, New Delhi Saturday, July 19, 2025, 08 ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

PCI Pharma Services has secured a new round of strategic investment, with Bain Capital joining existing lead investor Kohlberg and reinvestment partner Mubadala Investment Company to support ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...